Subtoxic intracellular trivalent chromium is not mutagenic: Implications for safety of chromium supplementation

Medical Hypotheses

Volumn 49, Issue 3, 1997, Pages 263-269

  McCarty, M F ^a  

^a Nutrition 21 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; FREE RADICAL;

AEROBIC METABOLISM; ARTICLE; CARCINOGENICITY; CHROMOSOME BREAKAGE; DIET SUPPLEMENTATION; ENDOCYTOSIS; GENOTOXICITY; MUTAGENESIS; NUTRITION; POINT MUTATION; PRIORITY JOURNAL; REDUCTION; SISTER CHROMATID EXCHANGE;

ANIMALIA;

EID: 0030756891     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90211-5     Document Type: Article

References (57)

1. Tkeshelashvili L K, Shearman C W, Zakour R A et al. Effects of arsenic, selenium, and chromium on the fidelity of DNA synthesis. Cancer Res 1989: 40: 2455-2460.
2. Bianchi V, Celotti L, Lanfranchi G et al. Genetic effects of chromium compounds. Mutation Res 1983; 117: 279-300.
3. Beyersmann D, Köster A. On the role of trivalent chromium in chromium genotoxicity. Toxicol Environ Chem 1987; 14: 11-22.
4. Snow E T. A possible role for chromium (III) in genotoxicity. Environ Hlth Perspect 1991; 92: 75-81.
5. Bridgewater L C, Manning F C R, Woo E S, Patierno S R. DNA polymerase arrest by adducted trivalent chromium. Mol Carcinogen 1994; 9: 122-133.
6. Fornace A J Jr, Seres D S, Lechner F F, Harris C C. DNA-protein crosslinking by chromium salts. Chem-Biol Interact 1981; 36: 345-354.
7. Tamino G, Peretta L, Levis A G. Effects of trivalent and hexavalent chromium on physico-chemical properties of mammalian cell nucleic acids and synthetic polynucleotides. Chem-Biol Interact 1981; 37: 309-319.
8. Snow E T, Xu L-S. Effects of chromium (III) on DNA replication in vitro. Biol Trace Elem Res 1989; 21: 61-71.
9. Feldman F J. The state of chromium in biological materials. Fed Proc 1968; 27: 482.
10. Levis A G, Bianchi V. Mutagenic and cytogenetic effects of chromium compounds. In: Langard S, ed. Biological and Environmental Aspects of Chromium. Amsterdam: Elsevier Biomedical Press, 1982; 171-208.
11. De Flora S, Zanacchi P, Camoirano A et al. Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutation Res 1984; 133: 161-198.
12. De Flora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of chromium compounds: A review. Mutation Res 1990; 238: 99-172.
13. Kortenkamp A, Beyersmann D. Uptake of chromium (III) complexes by erythrocytes. Toxicol Environ Chem 1987; 14: 23-32.
14. Levis A G, Majone F. Cytotoxic and clastogenic effects of soluble and insoluble compounds containing hexavalent and trivalent chromium. Br J Cancer 1981: 44: 219-235.
15. Elias Z, Schneider O, Aubry F et al. Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide. Carcinogenesis 1983; 4: 605-611.
16. Venier P, Montaldi A, Busi L et al. Genetic effects of chromium tannins. Carcionogenesis 1985; 6: 1327-1335.
17. Campbell C E, Gravel R A, Worton R G. Isolation and characterization of Chinese hamster cell mutants resistant to the cytotoxic effects of chromate. Somatic Cell Genet 1981; 7: 535-546.
18. Mertz W. Effects and metabolism of glucose tolerance factor. Nutr Rev 1975; 33: 129-135.
19. Evans G W, Bowman T D. Chromium picolinate increases membrane fluidity and rate of insulin internalization. J Inorg Biochem 1992; 46; 243-250.
20. Page T G, Southern L L, Ward T L, Thompson D L Jr. Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs. J Animal Sci 1993; 71: 656-662.
21. Evans G W, Meyer L K. Life span is increased in rats supplemented with a chromium-pyridine 2 carboxylate complex. Adv Sci Res 1994; 1: 19-23.
22. Kawanishi S, Inoue S, Sano S. Mechanism of DNA cleavage by sodium chromate(VI) in the presence of hydrogen peroxide. J Biol Chem 1986; 261: 5952-5958.
23. Wetterhahn K E, Hamilton J W, Aiyar J et al. Mechanism of chromium(VI) carcinogenesis. Biol Trace Elem Res 1989; 21: 405-411.
24. Shi X, Dalal N S. Evidence for a Fenton-type mechanism for the generation of OH radicals in the reduction of Cr(VI) in cellular media. Arch Biochem Biophys 1990; 281: 90-95.
25. Faux S P, Gao M, Chipman J K, Levy L S. Production of 8-hydroxydeoxy-guanosine in isolated DNA by chromium(VI) and chromium(V). Mutation Res 1992; 13: 1667-1669.
26. Nakamuro K, Yoshikawa K, Sayato Y, Kurata H. Comparative studies of chromosomal aberration and mutagenicity of trivalent and hexavalent chromium. Mutation Res 1987; 58: 175-181.
27. Levis A G, Majone F. Cytotoxic and clastogenic effects of soluble chromium compounds on mammalian cell cultures. Br J Cancer 1979; 40: 523-533.
28. Stella M, Montaldi A, Rossi R et al. Clastogenic effects of chromium on human lymphocytes in vitro and in vivo. Mutation Res 1982; 101: 151-164.
29. Stearns D M, Wise Sr J P, Patierno S R, Wetterhahn K E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 1995; 9: 1643-1648.
30. Ohno H, Hanaoka F, Yamada M. Inducibility of sister-chromatid exchanges by heavy-metal ions. Mutation Res 1982; 104: 141-145.
31. Anderson O. Effects of coal combustion products and metal compounds on sister chromatid exchange (SCE) in a macrophagelike cell line. Environ Hlth Persp 1983; 47: 239-253.
32. Lee N A, Reasner C A. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994; 17: 1449-1452.
33. Gentile M J, Hyde D, Schubert J. Chromium genotoxicity as influenced by complexation and rate effects. Toxicol Lett 1981; 7: 439-448.
34. Cupo D Y, Wetterhahn K E. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium(III) chloride in vivo. Cancer Res 1985; 45: 1146-1151.
35. Warren G, Schultz P, Bancroft D et al. Mutagenicity of a series of hexacoordinate chromium(III) compounds. Mutation Res 1981; 90: 111-118.
36. Langerwerf J S A, Bakkeren H A, Jongen W M T. A comparison of the mutagenicity of soluble trivalent chromium compounds with that of potassium chromate. Ecotoxicol Environ Safety 1985; 9: 92-100.
37. Gava C, Perazzolo M, Zentilin L et al. Genotoxic potentiality and DNA-binding properties of acetylacetone, maltol, and their aluminum(III) and chromium(III) neutral complexes. Toxicol Environ Chem 1989; 22: 149-157.
38. De Flora S, Camoirano A, Serra D, Bennicelli C. Genotoxicity and metabolism of chromium compounds. Toxicol Environ Chem 1989; 19: 153-160.
39. Guise C C. Evaluation of Chromium Picolinate in the Ames/Salmonella Mutagenesis Assay. Cambridge, Mass.: Biodevelopment Laboratories, June 12, 1995.
40. Langård S, One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am J Indust Med 1990; 17: 189-215.
41. Katz S A, Salem H. The toxicology of chromium with respect to its chemical speciation: a review. J Appl Toxicol 1993; 13: 217-224.
42. World Health Organization, International Agency for Research on Cancer. Chromium, nickel, and welding. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49, 1990: 118-141.
43. Sugden K D, Burris R B, Rogers S J. An oxygen dependence in chromium mutagenesis. Mutation Res 1990; 244: 239-244.
44. Sugden K D, Geer R D, Rogers S J. An oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. Biochemistry 1992; 31: 11626-11631.
45. Elias Z, Poirot O, Schneider O et al. Cellular uptake, cytotoxic and mutagenic effects of insoluble chromic oxide in V79 Chinese hamster cells. Mutation Res 1986; 169: 159-170.
46. Biedermann K A, Landolph J R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res 1990; 50: 7835-7842.
47. Galli A, Boccardo P, Del Carratore R et al. Conditions that influence the genetic activity of potassium dichromate and chromium chloride in Saccharomyces cerevisiae. Mutation Res 1985; 144: 165-169.
48. Friedman J, Shabtai F, Levy L S, Djaldetti M. Chromium chloride induces chromosomal aberrations in human lymphocytes via indirect action. Mutation Res 1987; 191: 207-210.
49. Lieberman S, Grojec P, Gondal J et al. Effects of chromium supplementation on sugar-induced elevations of blood pressure (BP) and lipid peroxidation in hypertensive rats. J Am Coll Nutr 1995; 14: 530.
50. Fabry L. Relation entre I'induction de micronoyaux dans les cellules de la moelle par les sels de chrome et leur pouvoir cancérigène. C R Soc Biol 1980; 174: 889-892.
51. Loveday K S. Evaluation of chromium picolinate in the rat in vivo chromosomal aberration assay. Worcester, Mass.: TSI Mason Laboratories, Inc., 1996.
52. Stearns D M, Belbruno J J, Wetterhahn K E. A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J 1995; 9: 1649-1655.
53. McCarty M F. Letters to the Editor. FASEB J 1996; 10: 365-367.
54. O'Flaherty E J. Personal communication.
55. Saner G. Toxicity of chromium. In: Chromium in Nutrition and Disease. New York: Alan R. Liss, 1980: 129.
56. Nielsen F H. Chromium. In: Shils M E, Olson J A, Shike M, eds. Modern Nutrition in Health and Disease, 8th edn. Philadelphia: Lea & Febiger, 1994: 264-268.
57. Schroeder H A. The role of chromium in mammalian nutrition. Am J Clin Nutr 1968; 21: 230-244.